[CLDX] QoQ Quarter Result on 31-Dec-2017 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
07-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- 85.43%
YoY- 88.11%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Revenue 941 2,763 4,068 3,456 3,924 3,829 1,534 -27.78%
PBT -7,243 -16,407 -118,897 -22,923 -31,563 -28,566 -34,261 -64.47%
Tax -14,912 -15,798 -765 -19,082 -5,200 1,276 5,098 -
NP -7,243 -16,407 -118,132 -3,841 -26,363 -28,566 -34,261 -64.47%
Tax Rate - - - - - - - -
Total Cost 8,184 19,170 122,200 7,297 30,287 32,395 35,795 -62.57%
Ratio Analysis
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
NP Margin -769.71 -593.81 -2,903.93 -111.14 -671.84 -746.04 -2,233.44 -50.81%
Per Share
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
EPS -0.66 -1.67 -12.61 -0.42 -3.05 -3.42 -4.19 -70.80%
EPS Diluted -0.66 -1.67 -12.61 -0.41 -3.05 -3.42 -4.19 -70.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.